Abbott Calibrator Kit Abbott SARS-CoV-2 IgG 1 X 2.0 mL For the Calibration of the Architect i System when used for the Qualitative Detection of IgG Antibodies to SARS-CoV-2 in Human Serum and Plasma - Each - 06R8601-EA

Abbott Calibrator Kit Abbott SARS-CoV-2 IgG 1 X 2.0 mL For the Calibration of the Architect i System when used for the Qualitative Detection of IgG Antibodies to SARS-CoV-2 in Human Serum and Plasma - Each - 06R8601-EA

Regular price $177.99
Sale price $177.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver: Jan23 - Jan26

Free Shipping & Returns: On orders above $79

Estimated deliver 5-7 days

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Abbott Calibrator Kit Abbott SARS-CoV-2 IgG 1 X 2.0 mL For the Calibration of the Architect i Sys...

Item Id 1164347
MF Id# 06R8601
Brand Abbott
Manufacturer Abbott
Country of Origin Ireland
Application Calibrator Kit
For Use With For the Calibration of the Architect i System when used for the Qualitative Detection of IgG Antibodies to SARS-CoV-2 in Human Serum and Plasma
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device N
Lot_Tracking_Flag N
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Supplier_ID 4446496
Test Name SARS-CoV-2 IgG
Test Type Antibody Test
UNSPSC Code 41116128
Volume 1 X 2.0 mL

Features

  • The SARS-CoV-2 IgG assay is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • The SARS-CoV-2 IgG assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection; at this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C 263a, to perform moderate or high complexity test
  • Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities
  • Negative results do not preclude acute SARS-CoV-2 infection
  • If acute infection is suspected, direct testing for SARS-CoV-2 is necessary
  • False positive results for SARS-CoV-2 IgG assay may occur due to cross-reactivity from pre-existing antibodies or other possible causes
  • Contains inactivated, cell-free, human blood-derived material, reactive for anti-SARS-CoV-2 IgG
  • Preservatives: sodium azide and antimicrobial agents
  • Prescription Use only; For In Vitro Diagnostic Use Only

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
About your query!
Recently Viewed